Turn Therapeutics, Inc. (TTRX)
8.12
-0.52
(-6.02%)
USD |
NASDAQ |
Nov 20, 15:59
Turn Therapeutics Shareholders Equity (Quarterly) : 5.692M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.692M |
| June 30, 2026 | 0.6869M |
| March 31, 2026 | 6.118M |
| Date | Value |
|---|---|
| December 31, 2025 | 5.757M |
| September 30, 2025 | 0.5567M |
| June 30, 2025 | 2.422M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Journey Medical Corp. | 32.25M |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.35M |
| Total Liabilities (Quarterly) | 10.66M |
| Debt to Equity Ratio | 1.095 |
| Current Ratio | 3.009 |
| Net Debt Paydown Yield | -0.28% |